跳至主要内容
临床试验/ACTRN12612000152820
ACTRN12612000152820招募中4 期

The incidence of infection and obstruction of newly inserted permanent tunneled dialysis catheters in chronic hemodialysis patients with using alteplase or trisodium citrate as a locking solution after the middle hemodialysis procedure.

Pavlina Richtrova, MD, PhD0 个研究点目标入组 80 人开始时间: 2012年2月3日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients with end stage kidney disease and newly inserted permanent tunneled dialysis catheter. Dialysis prescription = 3 times a week. Agreement with the trial participation.

排除标准

  • - anticoagulation treatment INR more than 1.4
  • - platelets count less than 60x109/l
  • - catheter insertion in vena cava inferior region (femoral vein)
  • - catheter insertion by a guide-wire exchange procedure
  • - active pericarditis with pericardial effusion
  • - known allergy or intolerance to alteplase or trisodium
  • - citrate pregnancy or breast-feeding

研究者

发起方
Pavlina Richtrova, MD, PhD

相似试验